No significant difference in the plasma levels of NAbs‐tau was observed between NCI and AD groups,112 and other studies have corroborated this, or have found no existence of such autoantibodies in patients with AD.83, 107, 109. The gene discussed is MAPT; the disease is Alzheimer disease.